Alexandria Real Estate: Upside Is Thinning Out, But It Remains
Alexandria Real Estate remains a top-tier lab-oriented REIT with strong cash flow, high tenant loyalty, and excellent management, making it a solid investment. ARE's financial health is robust, with a stellar balance sheet, high liquidity, and impressive credit ratings, ensuring stability and growth potential. Despite current valuations, the REIT's forward P/FFO and expected growth justify a $165/share price target, presenting an 18-21% annual upside.
2 Blue-Chip REITs That Are Still Undervalued
REITs are now strongly recovering. Even then, they still remain discounted. I highlight 2 blue-chip REITs that remain exceptionally cheap.
4 Top Dividend Stocks Yielding at Least 4% to Buy Without Hesitation This October
These companies offer higher-yielding payouts that seem likely to continue rising.
8 Dividend Stocks I'm Buying In October (Including A New Holding)
The stock market appears richly valued, with REITs and utilities outperforming tech stocks since the June CPI report, reflecting a defensive, yield-oriented investor shift. I plan to allocate dividends to the iShares 0-3 Month Treasury ETF for stability and also buy 8 dividend stocks, including a brand-new position. My dividend growth projection guesstimate involves analyzing management's earnings growth expectations, payout ratios, historical dividend growth, and potential obstacles.
Here's Why You Should Retain Alexandria Stock in Your Portfolio Now
ARE should gain from the solid demand for top-quality life science assets in key markets, though a vast development outlay raises the risks of cost overruns.
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
You can easily find stocks with huge dividend yields, but yield alone isn't enough to make a stock a buy. Dividend investors should favor companies that value rewarding investors via a growing payout.
Alexandria Sells Asset to Redeploy in Development, Redevelopment Moves
Keeping up with its capital-recycling strategy, Alexandria announces the completion of the sale of 1165 Eastlake Avenue East for $150 million.
1 REIT stock to buy, 1 to sell: Medical Properties Trust, Alexandria (ARE)
Real estate companies are doing relatively well as many of them continue navigating the much-talked about wall of maturities well and as the Federal Reserve points to interest rate cuts. The Vanguard Real Estate ETF (VNQ) surged to a high of $97.2 on Wednesday, 42% above its lowest level in 2023.
Alexandria Real Estate: Undervalued With Price At An Inflection Point
Alexandria Real Estate is currently undervalued considering normal levels of leasing, indicating that it has been oversold by the market following a contraction from peak growth in 2021/2022. In addition to strength in continued growth, the company has an established moat in the niche life sciences property ecosystem. It is focusing its attention on high-value mega campuses now. I estimate ARE's P/FFO ratio could expand toward 15 or more over the next 12 months. This indicates 18.5% upside from undervaluation alone.
These 2 REITs Are Still Great Buys After The Real Estate Rally
REITs are finally regaining in popularity. Some REITs have already risen by 10-20%. But opportunities remain. Here are 2 of them.
If I Was Retiring In 10-20 Years With 10 REITs - Part 1
This series will focus on REITs suitable for pre-retirees, addressing diversification and Buffett's "punch card" rule, emphasizing careful asset selection. Diversification is crucial for most investors, despite Buffett's advice; it mitigates risks from inevitable investment mistakes and balances portfolios. W. P. Carey, Brixmor Property, and Alexandria Real Estate are recommended REITs, each with strong fundamentals, growth potential, and strategic advantages.
Alexandria Real Estate: Cheap But Still Growing, It Remains A Buy
I revised my bearish stance on Alexandria Real Estate Equities (ARE) in June 2023 due to its low valuations and strong cash flows. Since then ARE has delivered acceptable positive total returns that were primarily driven by the dividend component. Over this time, however, ARE's cash generation has clearly improved, while the multiple has stayed almost the same.
